Real-life management of neovascular age-related macular degeneration (nAMD) in France: a nationwide observational study using retrospective claims data.

Jean-François Korobelnik Cécile Delcourt Catherine P Creuzot GarcherAsma MelaineJules ChassetuillierAnne LejeuneStève BénardLaure Dupont-Benjamin

Published in: Journal of medical economics (2021)

Current intravitreal anti-VEGF treatment and monitoring requirements place a considerable economic burden on the French healthcare system. New intravitreal therapies with extended dosing intervals and predictable efficacy might reduce demand for ophthalmology services.

Keyphrases

age related macular degeneration
cross sectional
vascular endothelial growth factor
healthcare
primary care
endothelial cells
artificial intelligence
mental health
big data
combination therapy
data analysis
affordable care act